Pathstone Family Office’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$313K Buy
11,271
+2,098
+23% +$65.6K ﹤0.01% 1290
2023
Q2
$256K Buy
9,173
+169
+2% +$4.94K ﹤0.01% 1036
2023
Q1
$285K Sell
9,004
-21,300
-70% -$811K ﹤0.01% 934
2022
Q4
$916K Buy
30,304
+5,013
+20% +$199K 0.01% 828
2022
Q3
$948K Buy
25,291
+15,991
+172% +$634K 0.01% 767
2022
Q2
$336K Buy
+9,300
New +$385K 0.01% 741
2019
Q2
Sell
-62
Closed -$2K 868
2019
Q1
$2K Hold
62
﹤0.01% 803
2018
Q4
$2K Buy
+62
New +$2.34K ﹤0.01% 478

Other funds holding SNV

Pathstone Family Office's SNV Position: Q3 2023 in Review

Pathstone Family Office increased its Synovus (SNV) stake by 23% in Q3 2023, buying an estimated $65.6K and bringing the position to 11,271 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

Pathstone Family Office first reported a position in SNV in Q4 2018 and has held it in 8 quarters since. The position peaked at $948K in Q3 2022. 371 funds tracked by Wall St. Rank hold SNV as of Q3 2023.

  • Pathstone Family Office held 11,271 shares of Synovus worth $313K as of Q3 2023.
  • Pathstone Family Office bought 2,098 Synovus shares in Q3 2023, an estimated $65.6K.
  • Synovus made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1290 holding.
  • Pathstone Family Office first reported a position in Synovus in Q4 2018 and has held it in 8 quarters since.
  • Pathstone Family Office's Synovus position peaked at $948K in Q3 2022.
  • 371 funds tracked by Wall St. Rank held Synovus as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.